Integrative transcriptomic and network pharmacology analyses explore potential mechanisms underlying the protective effects of Mailuoning oral liquid after intracerebral hemorrhage in mice

Background Secondary brain injury driven by neuroinflammation and blood–brain barrier (BBB) disruption contributes substantially to poor outcomes after intracerebral hemorrhage (ICH). Mailuoning oral liquid (MLN) has anti-inflammatory and vascular-protective activities; however, its protective effects and mechanisms in ICH remain unknown. Purpose To evaluate the protective effects of MLN after ICH and explore the potential underlying mechanisms. Methods A collagenase-induced ICH model was established in C57BL/6 J mice. Neurological deficits, brain injury, cerebral edema, BBB dysfunction, and BBB-related proteins were assessed. Transcriptomics and network pharmacology were integrated to identify candidate targets and pathways, followed by protein-level validation and phorbol 12-myristate 13-acetate (PMA) challenge. Results MLN improved neurological function, attenuated perihematomal injury and early hematoma burden, reduced cerebral edema and BBB leakage, increased claudin-5, occludin, and ZO-1, and decreased MMP-9. Transcriptomics identified 383 MLN-responsive genes enriched mainly in inflammatory and immune pathways, including NF-κB signaling. Network pharmacology independently identified 114 MLN–ICH targets and similarly highlighted inflammation-related pathways. Integrated analysis yielded 95 MLN-reversed ICH-responsive genes and three cross-supported candidates, F10, Ccl2, and Tnf. MLN reduced total NF-κB p65, TNF-α, IL-1β, and IL-6 protein expression, whereas PMA co-treatment partially attenuated MLN-associated improvements in neurological function and BBB-related protein expression. Conclusion MLN alleviates secondary brain injury and preserves BBB integrity after ICH. These protective effects may be associated with the modulation of NF-κB-related inflammatory responses and MMP-9-associated BBB alterations.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2026-11-13
DOI
https://doi.org/10.3389/fneur.2026.2001578
Primary Topic
Intracerebral and Subarachnoid Hemorrhage Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrative transcriptomic and network pharmacology analyses explore potential mechanisms underlying the protective effects of Mailuoning oral liquid after intracerebral hemorrhage in mice

Guo Liu, Zhixian Wan, Yu Zeng, Yali Zhang et al.
2 links
Frontiers in Neurology
Intracerebral and Subarachnoid Hemorrhage Research
article

Integrative transcriptomic and network pharmacology analyses explore potential mechanisms underlying the protective effects of Mailuoning oral liquid after intracerebral hemorrhage in mice

Guo Liu, Zhixian Wan, Yu Zeng, Yali Zhang, Fang Wang, Jiqin Zhang, Ying Tan
article en

Abstract

Background Secondary brain injury driven by neuroinflammation and blood–brain barrier (BBB) disruption contributes substantially to poor outcomes after intracerebral hemorrhage (ICH). Mailuoning oral liquid (MLN) has anti-inflammatory and vascular-protective activities; however, its protective effects and mechanisms in ICH remain unknown. Purpose To evaluate the protective effects of MLN after ICH and explore the potential underlying mechanisms. Methods A collagenase-induced ICH model was established in C57BL/6 J mice. Neurological deficits, brain injury, cerebral edema, BBB dysfunction, and BBB-related proteins were assessed. Transcriptomics and network pharmacology were integrated to identify candidate targets and pathways, followed by protein-level validation and phorbol 12-myristate 13-acetate (PMA) challenge. Results MLN improved neurological function, attenuated perihematomal injury and early hematoma burden, reduced cerebral edema and BBB leakage, increased claudin-5, occludin, and ZO-1, and decreased MMP-9. Transcriptomics identified 383 MLN-responsive genes enriched mainly in inflammatory and immune pathways, including NF-κB signaling. Network pharmacology independently identified 114 MLN–ICH targets and similarly highlighted inflammation-related pathways. Integrated analysis yielded 95 MLN-reversed ICH-responsive genes and three cross-supported candidates, F10, Ccl2, and Tnf. MLN reduced total NF-κB p65, TNF-α, IL-1β, and IL-6 protein expression, whereas PMA co-treatment partially attenuated MLN-associated improvements in neurological function and BBB-related protein expression. Conclusion MLN alleviates secondary brain injury and preserves BBB integrity after ICH. These protective effects may be associated with the modulation of NF-κB-related inflammatory responses and MMP-9-associated BBB alterations.

Frontiers in NeurologyVol. 17
Guizhou University (CN), Guizhou Provincial People's Hospital (CN)
Good health and well-being
Intracerebral and Subarachnoid Hemorrhage Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon